- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 86
Nonstandard Interventions to Treat CDI or Reduce the Risk of Recurrence
Clinical Questions Addressed by the CER (1 of 2)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | systematic review | key question
Clinical Questions Addressed by the CER (2 of 2)
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: key question | comparative effectiveness | systematic review
Clinical Questions Addressed by the CER (1 of 3)
Keywords: key questions | clinical questions | prevalence | incidence | natural history | musculoskeletal pain | children | adolescents
Clinical Questions Addressed by the CER (2 of 3)
Keywords: key questions | clinical questions | clinical diagnosis | musculoskeletal pain | children | adolescents | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value
Clinical Questions Addressed by the CER (3 of 3)
Keywords: key questions | clinical questions | musculoskeletal pain | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | children | adolescents | age | sex | race | ethnicity | comorbidity | recent infection | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value | referral decisions | clinical management | clinical uncertainty
The Comparative Effectiveness Review Development Process
Clinical Questions Addressed by the Comparative Effectiveness Review of Radiotherapy for Head and Neck Cancer
Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: | 2DRT | 3DCRT | adverse events | experience | head and neck cancer | IMRT | outcomes | proton beam therapy | quality of life | radiotherapy | survival | tumor control | comparative effectiveness
The CER Development Process
Clinical Questions Addressed by the CER for Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Keywords: benefits | clinical questions | harms | treatment modalities | comparative effectiveness
The CER Development Process (1)
Your slide tray is being processed.